Clinical Trial Update: Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tenofovir alafenamide for HBV prophylaxis after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Transplant Complication

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Fudan University | Conditions: HBV, POST LIVER TRANSPLANT | Phase 4 | Status: UNKNOWN